The Journal of
Clinical Psychiatry

Posttraumatic Stress Disorder

Original Research PTSD and Trauma March 15, 2006

Exacerbation of PTSD Symptoms With Use of Duloxetine

Michele L. Deneys ; Eileen P. Ahearn

J Clin Psychiatry 2006;67(3):393-394

Article Abstract

Letter to the Editor

Buy PDF for $40.00

Please sign in or purchase this PDF for $40.00.

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 85 • 2024 • Number 4

Read the Current Issue

Meta-Analysis

Changes in Cognition in Patients With Schizophrenia

Systematic Review

Diagnostic Assessment via Telehealth vs Face-to-Face

Original Research

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Original Research

Bridge Symptoms Between Borderline Personality and PTSD

Original Research

Gepirone-ER and Sexual Function in Patients with MDD

Original Research

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

View current Issue

Original Research

Evolution of Treatment Modalities for PTSD

December 12, 2024

The authors provide a bibliometric analysis of the most-cited articles published from 1990 to 2020 on evidence-based treatment modalities for PTSD to highlight significant developments in its understanding and management.

Mohsan Ali , Bisal Naseer , Muhammad T. Siddal , et al

Original Research

PTSD and Risk of Suicide Reattempt

November 25, 2024

After controlling for comorbid psychiatric conditions and other variables, PTSD was associated with suicide reattempt at 6 months (OR= 2.33) and with rehospitalization in psychiatric settings (OR=2.24) and nonpsychiatric...

Alice Demesmaeker , Fabien D’Hondt , Ali Amad , et al

Original Research

Hyperbaric Oxygen Therapy for Combat-Associated PTSD

November 10, 2024

Hyperbaric oxygen therapy demonstrated significant improvements on measures of depression in male veterans with combat-associated PTSD.

Keren Doenyas-Barak , Ilan Kutz , Erez Lang , et al

Exacerbation of PTSD Symptoms With Use of Duloxetine

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

ELSEWHERE:

FOLLOW US:

Exacerbation of PTSD Symptoms With Use of Duloxetine

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

Related Articles

Evolution of Treatment Modalities for PTSD

PTSD and Risk of Suicide Reattempt

Hyperbaric Oxygen Therapy for Combat-Associated PTSD

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles